Fore Bio is a precision oncology company initiating the development of cancer therapies guided by proprietary functional genomics. The company's main goal is to compassionately contribute to solving cancer. Fore Bio uses a high-throughput, high-precision functional genomics approach to open up new therapeutic options for patients whose cancers are defined by the multitude of rarer cancer-triggering mutations that remain largely untreatable today.